Thus, despite the clear peak observed in the exenatide trial, we cannot rule out the possibility that the increase of the GH levels is related to the stress reaction or represents a pulsatile nature of hormone secretion
GLP-1 receptor agonists increase first-phase insulin secretion and restore the incretin effect, both of which deteriorate during the progression toward diabetes [10]
Ly PT, Wu Y, Zou H, Wang R, Zhou W, Kinoshita A, et al
Hospitalization for unstable angina and coronary revascularization were analyzed separately and were not included in the composite endpoint
(2010) 89(6):S214650
In 2026, the focus has moved toward GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-dependent Insulinotropic Polypeptide) receptor agonists